Monthly Archives: June 2024

//June

MHRA Drug Safety Update: June 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 11 June 2024) has been published and includes articles on: Topiramate (Topamax®): introduction of new safety measures, including a Pregnancy Prevention Programme Warfarin: be alert to the risk of drug interactions with tramadol Letters and medicine recalls sent to healthcare [...]

The post MHRA Drug Safety Update: June 2024 appeared first on Community Pharmacy England.

By |June 20th, 2024|Lexpos News|Comments Off on MHRA Drug Safety Update: June 2024

New IT to streamlining Pharmacy First referrals

NHS England have announced that from 18th June 2024, clinical IT system suppliers will commence the roll out of a new feature enabling Pharmacy First referrals from general practices using EMIS Web Local Services or PharmRefer to flow into the workflows in pharmacy clinical systems. Referrals will be received into the same IT system workflow [...]

The post New IT to streamlining Pharmacy First referrals appeared first on Community Pharmacy England.

By |June 19th, 2024|bars, Lexpos News, referrals|Comments Off on New IT to streamlining Pharmacy First referrals

Medicine Supply Notification: Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler®

  Department of Health and Social Care (DHSC) has issued a medicine supply notification for Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler® MSN/2024/074 Tier 2 – medium impact Date of issue: 19th June 2024 Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler® is out of stock from late June until mid-July 2024. Flixotide® (fluticasone) Accuhaler® 100microgram, 250microgram and [...]

The post Medicine Supply Notification: Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler® appeared first on Community Pharmacy England.

By |June 19th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler®

Medicine Supply Notification: Triamcinolone acetonide suspension for injection vials (Kenalog® 40mg/1ml and Adcortyl® 50mg/5ml)

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Triamcinolone acetonide suspension for injection vials (Kenalog® 40mg/1ml and Adcortyl® 50mg/5ml) MSN/2024/073 Tier 2 – medium impact Date of issue: 18th June 2024 Triamcinolone acetonide suspension for injection vials (Kenalog® 40mg/1ml and Adcortyl® 50mg/5ml) are out of stock until w/c 24th [...]

The post Medicine Supply Notification: Triamcinolone acetonide suspension for injection vials (Kenalog® 40mg/1ml and Adcortyl® 50mg/5ml) appeared first on Community Pharmacy England.

By |June 18th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Triamcinolone acetonide suspension for injection vials (Kenalog® 40mg/1ml and Adcortyl® 50mg/5ml)

Medicine Supply Notification: Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials

TO NOTE: This MSN is the one of two covering supply issues with insulin vials. MSN/2024/057 issued on 20/05/24 covered Humulin® S (insulin soluble human). This MSN (MSN/2024/072) covers Humalog® (insulin lispro). CAUTION: These products have similar sounding names and appropriate risk minimisation strategies should be implemented to ensure actions are carried out for specific [...]

The post Medicine Supply Notification: Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials appeared first on Community Pharmacy England.

By |June 18th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials